Whole blood-based measurement of SARS-CoV-2-specific T cells reveals asymptomatic infection and vaccine immunogenicity in healthy subjects and patients with solid-organ cancers. (2022)

First Author: Scurr MJ
Attributed to:  Phase 1 COVID-19 Immunity - National Core Study funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/imm.13433

PubMed Identifier: 34775604

Publication URI: http://europepmc.org/abstract/MED/34775604

Type: Journal Article/Review

Volume: 165

Parent Publication: Immunology

Issue: 2

ISSN: 0019-2805